A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLC
Clinical trial NCT05844150 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05844150
- Sponsor
- Biotheus Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-01
- Primary completion
- 2024-05-10
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.